[go: up one dir, main page]

MX2019005368A - Generación de ovocitos humanos. - Google Patents

Generación de ovocitos humanos.

Info

Publication number
MX2019005368A
MX2019005368A MX2019005368A MX2019005368A MX2019005368A MX 2019005368 A MX2019005368 A MX 2019005368A MX 2019005368 A MX2019005368 A MX 2019005368A MX 2019005368 A MX2019005368 A MX 2019005368A MX 2019005368 A MX2019005368 A MX 2019005368A
Authority
MX
Mexico
Prior art keywords
generation
mii
human oocytes
oocytes
pbnt
Prior art date
Application number
MX2019005368A
Other languages
English (en)
Inventor
Temiakov Dmitry
Mitalipov Shoukhrat
Marti-Gutierrez Nuria
Original Assignee
Univ Oregon Health & Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oregon Health & Science filed Critical Univ Oregon Health & Science
Publication of MX2019005368A publication Critical patent/MX2019005368A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A61B17/425—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
    • A61B17/435—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for embryo or ova transplantation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/04—Cells produced using nuclear transfer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Se proporcionan metodos de generación de ovocitos humanos funcionales después de la transferencia nuclear de los genomas del primer cuerpo polar (PB1) de los ovocitos de la metafase II (MII) en citoplasma MII donante enucleado (PBNT) y usando técnicas de reemplazo mitocondrial para eludir la transmisión de enfermedades del ADNmt de la madre al del niño.
MX2019005368A 2016-11-09 2017-11-08 Generación de ovocitos humanos. MX2019005368A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662419638P 2016-11-09 2016-11-09
US201662427546P 2016-11-29 2016-11-29
PCT/US2017/060720 WO2018089553A1 (en) 2016-11-09 2017-11-08 Generation of human oocytes

Publications (1)

Publication Number Publication Date
MX2019005368A true MX2019005368A (es) 2019-10-21

Family

ID=62109407

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019005368A MX2019005368A (es) 2016-11-09 2017-11-08 Generación de ovocitos humanos.

Country Status (5)

Country Link
US (1) US11718825B2 (es)
AU (1) AU2017359447A1 (es)
BR (1) BR112019009430A2 (es)
MX (1) MX2019005368A (es)
WO (1) WO2018089553A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7346239B2 (ja) * 2019-10-25 2023-09-19 三星電子株式会社 解析方法及び解析システム
CN113736876B (zh) * 2021-10-14 2023-08-11 胜亚生物科技(厦门)有限公司 一种快速检测染色体数目异常的试剂盒及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143564A (en) * 1998-07-07 2000-11-07 University Of Hawaii Use of the polar body chromosomes for the production of embryos and normal offspring
WO2008144580A2 (en) 2007-05-17 2008-11-27 Oregon Health & Science University Primate stem cells produced by somatic cell nuclear transfer
WO2009015036A1 (en) 2007-07-20 2009-01-29 Oregon Health & Science University Parthenote-derived stem cells and methods of making and using them
WO2010124123A1 (en) 2009-04-24 2010-10-28 Oregon Health & Science University Methods for mitochondrial dna replacement in oocytes
US9434960B2 (en) 2012-12-06 2016-09-06 New York Stem Cell Foundation, Inc. Methods for making and using modified oocytes
EP2997131A4 (en) 2013-05-13 2016-10-26 Univ Oregon Health & Science HUMAN PLURIPOTENTIAL STEM CELLS MADE BY SOMATIC CELL CORE TRANSFER
WO2018195418A1 (en) 2017-04-20 2018-10-25 Oregon Health & Science University Human gene correction

Also Published As

Publication number Publication date
US20190292519A1 (en) 2019-09-26
BR112019009430A2 (pt) 2019-07-30
AU2017359447A1 (en) 2019-05-23
US11718825B2 (en) 2023-08-08
WO2018089553A1 (en) 2018-05-17

Similar Documents

Publication Publication Date Title
MX394516B (es) Moléculas pequeñas contra cereblon para mejorar la función efectora de los linfocitos t.
MX2024001457A (es) Metodos para generar animales geneticamente modificados.
MX2024000006A (es) Proteinas de fusion inmunomoduladoras y sus usos.
GB2570593A (en) Methods relating to intestinal organ-on-a-chip
DOP2016000177A (es) Compuestos derivados y composiciones de n-azaspirocicloalcano n-heteroaril sustituido para inhibir la actividad de shp2
MX2018002301A (es) Composiciones de glucano y usos de las mismas.
EP3350313A4 (en) DERIVATION OF LIVER ORGANOIDS FROM HUMAN PLURIPOTENTIAL STEM CELLS
CL2018000070A1 (es) Modulares de diaciglicerol aciltransderasa 2 (dgta2)
BR112017018919A8 (pt) Proteínas de fusão imunomoduladoras e seus usos
EA202090931A3 (ru) Композиции и способы перепрограммирования tcr с помощью гибридных белков
MX2017002605A (es) Receptores de antigeno quimerico condicionalmente activos para celulas t modificadas.
MX392707B (es) LINFOCITOS T ACTIVADOS POR BiTE EX VIVO.
PE20200691A1 (es) Enfoque con arni para la proteccion de cultivos contra plagas
PE20170010A1 (es) Composiciones y metodos para modular la expresion del factor b del complemento
EP4268860A3 (en) Compositions, devices, kits and methods for attaching stent-containing medical devices to tissue
SG10201902811TA (en) High efficiency, high throughput generation of genetically modified mammals by electroporation
CL2016003277A1 (es) Métodos para preparar análogos de nucleótido sustituidos
MX2021000295A (es) Compuestos inmunomoduladores dimericos contra mecanismos basados en cereblon.
PH12018502402A1 (en) Methods of treating autoimmune disease using allogeneic t cells
PL412337A1 (pl) Wziernik nosowy
ES2722427T3 (es) Dispositivo y procedimiento para el calentamiento inductivo de cubiertas de envasado
MX388202B (es) Métodos para generar productos de esmalte in vitro.
MX2020004600A (es) Constructos de oligonucleotidos y usos de estos.
EP3804725A3 (en) Nanomaterial compositions, synthesis, and assembly
CL2021000005A1 (es) Tiofencarboxamidas sustituidas y análogos de las mismas